White Paper for the Center for Health & Pharmaceutical Law & Policy, Seton Hall Law School
62 Pages Posted: 3 Dec 2009 Last revised: 11 Feb 2014
Date Written: November 30, 2009
This White Paper makes several policy recommendations to eliminate or manage the conflicts of interest that arise pursuant to the compensation arrangements between investigators and their institutions with drug and medical device manufacturers as they affect the recruitment and enrollment of human research subjects in clinical trials. The paper seeks to accomplish overall financial neutrality as between treatment and research, so that physicians' decisions regarding inclusion of patients in clinical trials is unaffected by their own financial interests.
Keywords: conflict of interest, pharmaceutical, clinical trials
Suggested Citation: Suggested Citation
Boozang, Kathleen and Coleman, Carl H. and Miller, Tracy E. and Greenwood, Kate and Koch, Valerie Gutmann and Handler-Hutchinson, Simone and Finizio, Catherine, Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight (November 30, 2009). White Paper for the Center for Health & Pharmaceutical Law & Policy, Seton Hall Law School. Available at SSRN: https://ssrn.com/abstract=1515762 or http://dx.doi.org/10.2139/ssrn.1515762